Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Centrosomal protein TALPID3, encoded by the KIAA0586 gene, is a highly conserved, ubiquitously expressed protein essential for the formation of primary cilia in vertebrate cells[1][3][5]. It localizes to the basal body and adjacent centriole at the base of primary cilia, where it is critical for correct centrosome function, cell polarity, and the docking and formation of cilia[1][3][5]. TALPID3 is required for the transduction of Hedgehog signaling, intracellular trafficking, and microtubule dynamics which impact organ development and tissue patterning[1][3]. Loss-of-function mutations in KIAA0586 cause a range of severe ciliopathies, most notably Joubert syndrome (JBTS23)—a neurodevelopmental disorder with brain, kidney, and skeletal abnormalities—and short-rib thoracic dysplasia (SRTD14)[2][3][4]. TALPID3 has documented functional interactions with proteins such as PCM1, Cep120, CP110, Rab8, and Mib1, all involved in centrosomal structure and ciliogenesis[1][3]. Notably, TALPID3 has not been reported as a therapeutic drug target or used clinically as a biomarker[3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Centrosomal protein TALPID3 (TALPID3).